Furthermore, Ahmadian el al. demonstrated that Azilsartan, an AT1R antagonist, elevated apoptosis at least partially by increasing BAX mRNA expression in HepG2 hepatocellular carcinoma cells (Ahmadian et al., 2018[3]). This evidence concerns the gene BAX and hepatocellular carcinoma.